Association between MTHFR polymorphisms and acute myeloid leukemia risk: a meta-analysis.

Indeterminate cell histiocytosis (ICH) is a rare proliferative disorder, in which the predominant cells share morphologic and immunophenotypic features from both Langerhans

AKT, AKT serine/threonine kinase; AML, acute myeloid leukemia; AMPK, AMP-activated protein kinase; ALL, acute lymphoblastic leukemia; B-ALL, B cell acute lymphoblastic leukemia;

We studied the demographics and response to treatment of patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) between 1989 and 2000 in Teresina, Piauí,

polymorphisms, we evaluated the influence of C677T and A1298C polymorphisms in the methylenetetrahydrofolate reductase gene (MTHFR), of A2756G polymorphism in the methionine

PFS: progression-free survival; OS: overall survival; AML: acute myeloid leukemia; ALL: acute lymphoblastic leukemia; CR: complete remission; RR: response rate; CMML:

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to

C–2578A and MTHFR C677T polymorphisms in patients with CAD and in a group without angiographic signs of the disease, and evaluated the association between these polymorphisms

Studies were included in the meta-analysis if they met the following criteria: (1) the study as- sessed the association between hepatocellular carcinoma risk and COX-2